Change - Announcement of Cessation::Announcement of Cessation

Issuer & Securities

Issuer/ Manager
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
Securities
TIANJIN PHARM DA REN TANG GRP - CNE100000924 - T14
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
15-May-2026 21:04:27
Status
New
Announcement Sub Title
Announcement of Cessation
Announcement Reference
SG260515OTHRS5HR
Submitted By (Co./ Ind. Name)
Jiao Yan
Designation
Secretary to the Board
Description (Please provide a detailed description of the event in the box below)
Announcement of Cessation of Independent and Non-Executive Director

Additional Details

Name of person
Liew Yoke Pheng Joseph
Age
70
Is effective date of cessation known?
Yes
If yes, please provide the date.
15/05/2026
Detailed reason(s) for cessation
Mr. Liew Yoke Pheng Joseph, having served on the Board as an Independent and Non-Executive Director for six (6) years, retired as a Director of the Company at the conclusion of the Company s annual general meeting held on 15 May 2026 upon the expiry of his term of office.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of appointment to current position
05/06/2020
Job title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independnet and Non-Executive Director, Chairman of the Audit Committee and a member of the Remuneration Committee
Role and responsibilities
Duties as an Independnet and Non-Executive Director, the Chairman of the Audit Committee and a member of the Remuneration Committee
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of independent directors currently resident in Singapore (taking into account this cessation)
2
Do independent directors make up at least one-third of the board (taking into account this cessation)?
No
Number of cessations of appointments specified in Mainboard Rule 704(7) or Catalist Rule 704(6) over the past 12 months
3
Shareholding interest in the listed issuer and its subsidiaries
No
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries
NIL
Other Directorships
Past (for the last 5 years)
Chairman and Executive Director of Hoe Leong Corporation Ltd.

Independent, Non-Executive Chairman, Chairman of the Audit Commit tee and member of the Nominating Committee and Remuneration Committee of Grand Venture Technology Limited
Present
Independent, Non-Executive Director, Chairman of the Audit Committee and member of the Nominating Committee of Embracing Future Holdings Limited (Formally known as Biolidics Limited)

Independent director of Lew Foundation

Director of Char Yong (Dabu) Foundation